SCHEMBL7705833

SCHEMBL7705833

FC(F)(F)c1c[c]cc(C(F)(F)F)c1-c1cccc(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
GLA P06280 1/20 0.45
HTT P42858 1/20 0.45
AR P10275 2/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11287918 0.81 MAP4K4 (0.45) MAPT
SCHEMBL7465724 0.77 KIF11 (0.41) GAAHPGDKDM4EALDH1A1LMNA
SCHEMBL7699908 0.77 AHR (0.45) HTTARKMT2AMEN1
SCHEMBL1403790 0.77 PDK2 (0.38) GAAHPGDKDM4EALDH1A1GLA
SCHEMBL7509512 0.76 ALOX5 (0.42) ALOX5IKBKETAAR1
SCHEMBL7707668 0.76 PTPN5 (0.43) HPGDKDM4EALDH1A1HTTAR
SCHEMBL3833481 0.71 SCN9A (0.53) GAAHPGDKDM4EALDH1A1LMNA
SCHEMBL3480544 0.71 GABRA2 (0.52) GAAHPGDALDH1A1GABRPGABRD
SCHEMBL27777918 0.71 ALOX5 (0.50) KDM4EALOX5PGRTAAR1
SCHEMBL7705830 0.71 GAA (0.39) GAAHPGDKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242399-A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB S.A. (BE) 2002-09-25 EP disclosed
WO-2001046167-A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB, S.A. (BE) 2001-06-28 WO disclosed